Literature DB >> 7713402

Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases.

P A Locke1, P M Conneally, R E Tanzi, J F Gusella, J L Haines.   

Abstract

An increased frequency of the apolipoprotein E type 4 allele (APOE-4) has previously been associated with both late-onset sporadic and late-onset familial Alzheimer disease (AD) [Strittmatter et al. (1993) Proc Natl Acad Sci USA 90:1977-1981; Saunders et al. (1993a) Neurology 43:1467-1472]. To further investigate this association we genotyped affected individuals from 92 separate AD pedigrees including both early- and late-onset cases. An increased frequency of the APOE-4 allele was found only among the late-onset cases, both familial and sporadic, confirming the earlier reports. In addition, age at onset was significantly decreased in the APOE-4 homozygotes (in late onset families) compared to either APOE-4 heterozygotes or individuals not carrying an APOE-4 allele. We also observed a significantly decreased frequency of the APOE-2 allele in both the early- and late-onset familial cases. These results strengthen the argument for a direct role of APOE in susceptibility to AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713402     DOI: 10.1002/gepi.1370120108

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  13 in total

1.  Structural brain changes in normal individuals with a maternal history of Alzheimer's.

Authors:  Valentina Berti; Lisa Mosconi; Lidia Glodzik; Yi Li; John Murray; Susan De Santi; Alberto Pupi; Wai Tsui; Mony J De Leon
Journal:  Neurobiol Aging       Date:  2011-02-12       Impact factor: 4.673

2.  Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

Authors:  H Bickeböller; D Campion; A Brice; P Amouyel; D Hannequin; O Didierjean; C Penet; C Martin; J Pérez-Tur; A Michon; B Dubois; F Ledoze; C Thomas-Anterion; F Pasquier; M Puel; J F Demonet; O Moreaud; M C Babron; D Meulien; D Guez; M C Chartier-Harlin; T Frebourg; Y Agid; M Martinez; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

3.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.

Authors:  T Arendt; C Schindler; M K Brückner; K Eschrich; V Bigl; D Zedlick; L Marcova
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

5.  Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability.

Authors:  Heike Hering; Chih-Chun Lin; Morgan Sheng
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

6.  Exploratory analysis of seven Alzheimer's disease genes: disease progression.

Authors:  Agustín Ruiz; Isabel Hernández; Maiteé Ronsende-Roca; Antonio González-Pérez; Emma Rodriguez-Noriega; Reposo Ramírez-Lorca; Ana Mauleón; Concha Moreno-Rey; Lucie Boswell; Larry Tune; Sergi Valero; Montserrat Alegret; Javier Gayán; James T Becker; Luis Miguel Real; Lluís Tárraga; Clive Ballard; Michael Terrin; Stephanie Sherman; Haydeh Payami; Oscar L López; Jacobo E Mintzer; Mercè Boada
Journal:  Neurobiol Aging       Date:  2012-10-01       Impact factor: 4.673

7.  Association of parental dementia with cognitive and brain MRI measures in middle-aged adults.

Authors:  S Debette; P A Wolf; A Beiser; R Au; J J Himali; A Pikula; S Auerbach; C Decarli; S Seshadri
Journal:  Neurology       Date:  2009-12-09       Impact factor: 9.910

Review 8.  Genetic dissection of Alzheimer disease, a heterogeneous disorder.

Authors:  G D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele.

Authors:  Jozsef Gal; Yuriko Katsumata; Haining Zhu; Sukanya Srinivasan; Jing Chen; Lance Allen Johnson; Wang-Xia Wang; Lesley Renee Golden; Donna M Wilcock; Gregory A Jicha; Matthew D Cykowski; Peter Tobias Nelson
Journal:  Am J Pathol       Date:  2021-12-24       Impact factor: 4.307

10.  APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

Authors:  Sigrid B Sando; Stacey Melquist; Ashley Cannon; Michael L Hutton; Olav Sletvold; Ingvild Saltvedt; Linda R White; Stian Lydersen; Jan O Aasly
Journal:  BMC Neurol       Date:  2008-04-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.